Cargando…
Low dose vs high dose tocilizumab in COVID-19 patients with hypoxemic respiratory failure
PURPOSE: Tocilizumab has been shown to decrease mortality when used concomitantly with steroids in COVID-19 with 8 mg/kg (max 800 mg) being the standard dose. Our study sought to assess whether a low dose (400 mg) shows similar benefit compared to a high dose for COVID patients concurrently on the s...
Autores principales: | Chung, Juri, Brosnahan, Shari B., Islam, Shahidul, Altshuler, Diana, Spiegler, Peter, Li, Wai Kin, Wang, Wai Man, Chen, Xian Jie Cindy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084735/ https://www.ncbi.nlm.nih.gov/pubmed/37043893 http://dx.doi.org/10.1016/j.jcrc.2023.154291 |
Ejemplares similares
-
Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients
Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without
Increased Infection Risk
por: Brosnahan, Shari B., et al.
Publicado: (2021) -
LUNG ABSCESSES IN A PATIENT TREATED WITH TOCILIZUMAB FOR COVID-19 PNEUMONIA COMPLICATED BY SEVERE HYPOXEMIC RESPIRATORY FAILURE
por: Kashin, Maxim, et al.
Publicado: (2020) -
EFFECT OF HIGH- VS LOW-DOSE OF DEXAMETHASONE ON INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS IN ACUTE HYPOXEMIC RESPIRATORY FAILURE IN SARS COV-2 PNEUMONIA
por: RAHMAN, OMAR, et al.
Publicado: (2022) -
An Unusual Suspect Causing Hypoxemic Respiratory Failure
por: Aqeel, Masooma, et al.
Publicado: (2017) -
Hypoxemic Respiratory Failure: Evidence, Indications, and Exclusions
por: Abrams, Darryl, et al.
Publicado: (2015)